Products

What will AGI do for Alphaprodine?

This classification denotes an opioid receptor agonist with the molecular formula C16H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 001O2254AC, chemically known as 1,3-dimethyl-4-phenyl-4-propionoxypiperidine but generally known as alphaprodine, which bears US NIH Compound Identifier 6471. Alphaprodine comes in base and hydrochloride forms. European Medicines Agency schedules Alphaprodine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05366MIG. The term ALPHAPRODINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). ALPHAPRODINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alphaprodine under HS 29333999 and SITC 51574. As of Q4 2014, ALPHAPRODINE remains the US FDA Preferred Term for this commodity. Alphaprodine bears US NLM identifiers UMLS ID C0002327 and NCI Concept Code C83528. SMILES: O(C1(C(CN(CC1)C)C)C1CCCCC1)C(=O)CC.

How AGI delivers it

Four ways AGI delivers for Alphaprodine

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Alphaprodine, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Alphaprodine, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Alphaprodine connects

measured by

  • Active Ingredient Potencymodel
  • Compound Puritymodel
  • Residual Solventmodel